TransMedics Group Inc. has released a presentation highlighting its advancements in organ transplantation technology. The company detailed the limitations of traditional cold storage for donor organs, noting issues such as severe time-dependent injury and lack of assessment capabilities, which contribute to significant underutilization of donor organs in the United States. The presentation introduced the Organ Care System $(OCS)$ platform, described as the only multiorgan, portable warm perfusion platform, which aims to minimize ischemic damage, enable ex-vivo organ optimization, and allow continuous clinical assessment. The latest generation OCS Kidney technology features integrated biosensors, continuous data capture, and near-physiologic preservation for extended organ viability and functional assessment. The company also referenced a substantial body of prospective clinical evidence supporting the platform's effectiveness with both DBD and DCD organs. You can access the full presentation through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief on January 12, 2026, and is solely responsible for the information contained therein.